Mackenzie Financial’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-58,257
| Closed | -$163K | – | 1476 |
|
|
2022
Q2 | $163K | Buy |
58,257
+3,975
| +7% | +$11.1K | ﹤0.01% | 1303 |
|
|
2022
Q1 | $310K | Buy |
54,282
+147
| +0.3% | +$840 | ﹤0.01% | 1100 |
|
|
2021
Q4 | $494K | Buy |
54,135
+23,897
| +79% | +$218K | ﹤0.01% | 1002 |
|
|
2021
Q3 | $323K | Sell |
30,238
-228
| -0.7% | -$2.44K | ﹤0.01% | 1103 |
|
|
2021
Q2 | $473K | Buy |
30,466
+6,040
| +25% | +$93.8K | ﹤0.01% | 987 |
|
|
2021
Q1 | $396K | Sell |
24,426
-1,084
| -4% | -$17.6K | ﹤0.01% | 981 |
|
|
2020
Q4 | $540K | Buy |
+25,510
| New | +$540K | ﹤0.01% | 821 |
|
|
2020
Q1 | – | Sell |
-8,960
| Closed | -$211K | – | 1115 |
|
|
2019
Q4 | $211K | Buy |
+8,960
| New | +$211K | ﹤0.01% | 1029 |
|